NYMXF (Nymox Pharmaceutical) Institutional Ownership: 0.04% (As of Aug. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Nymox Pharmaceutical Institutional Ownership?

Nymox Pharmaceutical NYMXF Institutional Ownership is 0.04% as of Aug. 17, 2026.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Nymox Pharmaceutical's institutional ownership is 0.04%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Nymox Pharmaceutical's Insider Ownership is 29.92%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Nymox Pharmaceutical's Float Percentage Of Total Shares Outstanding is 65.14%.

Nymox Pharmaceutical Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Nymox Pharmaceutical's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nymox Pharmaceutical Institutional Ownership Chart

Nymox Pharmaceutical Historical Data

The historical data trend for Nymox Pharmaceutical can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 0.01 0.01 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08

Nymox Pharmaceutical Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.04% mean?
Nymox Pharmaceutical (NYMXF) has a Institutional Ownership of 0.04% as of Aug. 17, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Nymox Pharmaceutical and its competitors.
Is Nymox Pharmaceutical's Institutional Ownership too high?
Nymox Pharmaceutical's current Institutional Ownership is 0.04%.
How does Nymox Pharmaceutical's Institutional Ownership compare to LYRA and RNAZ?
Nymox Pharmaceutical's Institutional Ownership of 0.04% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Nymox Pharmaceutical and its competitors. Nymox Pharmaceutical's current Institutional Ownership is 0.04%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nymox Pharmaceutical stock overvalued right now?
Nymox Pharmaceutical (NYMXF) has a current Institutional Ownership of 0.04%. The current Institutional Ownership is 0.04%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Nymox Pharmaceutical (NYMXF), the current Institutional Ownership is 0.04% as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nymox Pharmaceutical Business Description

Address Bay & Deveaux Streets, Nassau, BHS
Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and low-grade localized prostate cancer. The company also has an extensive patent portfolio covering its investigational drug as well as other therapeutic and diagnostic indications. It also has U.S. and patent rights for the use of statin drugs for the treatment and prevention of Alzheimer's disease. The company operates in one reportable segment, focused on researching and developing products for the aging population.